Nouscom is a biotech company developing new cancer treatments that utilize the immune system to fight cancer. It focuses on creating therapies based on neoantigens to enhance the body's natural defenses against cancer.
Founded
2015
Total Funding
$100M+
Total Rounds
4
First Raise
May 17, 2016
Latest Raise
Oct 19, 2026
New funding rounds in your inbox every week · No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 10/19/2026 | |||
3 more funding rounds available
Upgrade to Premium to view all historical funding rounds
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week · Free